COMMUNIQUÉS West-GlobeNewswire
-
Arizona Nonprofit Launches “America 250” Fundraiser Featuring 250 Winners to Support Childhood Blindness Research
11/06/2026 -
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
11/06/2026 -
Sharecare wins 14 Digital Health Awards in Spring 2026 competition
11/06/2026 -
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
11/06/2026 -
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
11/06/2026 -
Spectral AI to Participate in 2026 British Burn Association Annual Conference
11/06/2026 -
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
11/06/2026 -
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
11/06/2026 -
VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor
11/06/2026 -
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
11/06/2026 -
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
11/06/2026 -
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders
11/06/2026 -
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
11/06/2026 -
Loma Linda University Health and Nudj Health Launch Integrated Whole-Person Primary Care Model Designed to Advance the Future of Healthcare Delivery
11/06/2026 -
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
11/06/2026 -
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM
11/06/2026 -
Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
11/06/2026 -
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
11/06/2026 -
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
11/06/2026
Pages